02.08.2011 • News

Luke Kissam Elected CEO of Albemarle

Luke C. Kissam will take over as Albemarles CEO on Sept.1.
Luke C. Kissam will take over as Albemarle's CEO on Sept.1.

Albemarle has promoted Luke C. Kissam to CEO, effective Sept.1. Kissam joined Albemarle in September 2003 as vice president, general counsel and corporate secretary and served as senior vice president, manufacturing and law, and corporate secretary from January 2008 until his promotion to president in March 2010.

Prior to joining Albemarle, Kissam served as vice president, general counsel and secretary of Merisant, having previously served as associate general counsel of Monsanto.

Current CEO Mark C. Rohr will continue as executive chairman of the Albemarle Board of directors.   

 

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.